HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Faust, F. B. Articles by Etris, S. Search for Related Content PubMed Articles by Faust, F. B. Articles by Etris, S.

Staphylococcal Vaccine-Toxoid Combined in Human Immunization

From the Department of Research of The National Drug Company

Abstract

From the results obtained by one of us (Etris: 1943, THIS JOURNAL 309) in the immunization of rabbits with staphylococcal vaccine-toxoid, and because of its direct application to human treatment, it seemed advisable to obtain information on the effect of such a combination in the stimulation of antibacterial and antitoxic antibodies in the normal individual and in patients with infections due to the staphylococcus. The formula of the combination selected for human use contained 2000 million Staphylococcus aureus and 1000 original MND of staphylococcal toxoid in each ml,¹ giving a preparation slightly weaker in both respects than the usual single vaccine or toxoid preparation.

The individuals selected for study represented two small groups: One group consisted of eleven men from 20 to 50 years of age who did not show evidence of pathology. The other group of five patients either had lesions of known staphylococcal etiology or this organism appeared to be the underlying cause of the condition.

Footnotes

¹ Product Staphylococcus "Vatox" of the National Drug Co.